SOCS1 is a key regulator of cytokine signaling and is important for maintaining balance in the immune system. It is thought to participate in negative feedback loops in cytokine signaling and may be an important signal for the regulation of dendritic cell (DC) maturation. However, it remains unclear whether DCs transduced with SOCS1 exhibit characteristics of regulatory DCs and induce allogeneic T-cell hyporesponsiveness. In this study, we constructed adenoviral vector coding SOCS1 ( 
Introduction
Dendritic cells (DCs), which are potent professional antigenpresenting cells (APCs), play a pivotal role in initiating antigen-specific immune responses (1) . Mature DCs, which express high levels of major histocompatibility complex (MHC) and costimulatory molecules on their surface, can induce an immune response. However, immature DCs with a deficiency in MHC and costimulatory molecules cause immune deviation from Th1 to Th2 cell subsets, provoke antigen-specific T-cell hyporesponsiveness and induce Agspecific tolerance (2, 3) . Therefore, maintaining iDC in an immature steady state is critical for inducing long-term immune tolerance in vivo. Recent studies revealed a certain DC subset with potent immunoregulatory properties in humans and mice, which can be generated by culturing bone marrow-derived dendritic cells (BMDCs) in the presence of inhibitory cytokines such as interleukin (IL)-10 or transforming growth factor (TGF)- (4, 5) . This DC subset possesses characteristics of a low-expressing mature marker (CD83) and costimulatory molecules that can induce T-cell hyporesponsiveness, promote the generation of regulatory T cells (Tregs), and prolong allograft survival. Therefore, they are designated as regulatory DCs (2, (6) (7) (8) . Some antiinflammatory mediators (e.g., TGF-, IL-10, 1,25-dihydroxyvitamin D3, immunodepressant mycophenolate, vasoactive intestinal peptide (VIP), and soluble tumor necrosis factor (TNF)- receptor), used alone or in combination, can interrupt DC maturation to induce regulatory DC generation (9) (10) (11) (12) . At the same time, the inhibition of certain key cytokine signals can keep DCs in an immature state or differentiate them into regulatory DCs (13, 14) . Thus, modulation of the differentiation and maturation process may contribute to the decision of DCs to differentiate into regulatory DCs.
Suppressors of cytokine signaling (SOCS) proteins regulate the intensity, duration, and quality of responses to cytokines, such as interleukins, interferon (IFN)-, and growth hormone (GH). SOCS protein expression is induced by cytokines; once expressed, SOCS proteins function as components of a negative feedback loop to inhibit the cytokine signaling pathway (15, 16) . SOCS1, also called JAB (JAK-binding protein) or SSI l (STAT-induced STAT inhibitor l), belongs to the SOCS family with the SH2 domain. Studies have demonstrated that SOCS1 plays a pivotal role in regulating macrophage, T cell, and dendritic cell activation, development, and differentiation (17, 18) . In SOCS1 −/− mouse, the development process of T cells in the thymus was in disorder, and the peripheral T cells exhibited abnormal activation accompanied by Th2 cells in a disturbed state. SOCS1 −/− macrophages produce large amounts of inflammatory cytokines in response to lipopolysaccharide (19) , while the macrophages overexpressing SOCS1 can reduce adenovirus vector-induced innate immune responses (20) . Recent research revealed that silencing the SOCS1 gene in DCs with the RNA interference technique can contribute to DC maturity and thus increase their antitumor immunity (21) . All these studies indicated that SOCS1 protein indeed participates in the regulation of DC maturation and function, and is a genetic engineering target to manipulate DC.
In this study, we constructed the adenoviral vector coding SOCS1 gene and investigated the effect of SOCS1 gene overexpression on the maturation, activation, and function of BMDCs. Our research demonstrated that DC-SOCS1 exhibited resistant to maturation and activation induction, increased IL-10 secretion, and induced allogeneic T-cell hyporesponsiveness in vitro and in vivo, indicating that SOCS1 overexpression promoted regulatory DC generation. With the murine heterotopic allogeneic heart transplantation model, we further confirmed that DC-SOCS1 infusion could induce CD4 + CD25 + regulatory T-cell generation and prolong allograft survival.
Materials and Methods

Animals
, and C3H (H-2 k ) mice, 8 to 10 weeks old, were obtained from the Joint Ventures Sipper BK Experimental Animal Co. (Shanghai, China). All mice were fed ad libitum with standard murine chow and housed in a specific pathogen-free environment. Animal study was approved by the Animal Care Committee of the second military medical university and was performed in accordance with our institutional guidelines.
Reagents
Recombinant mouse granulocyte-macrophage colonystimulating factor (GM-CSF) and IL-4 were purchased from PeproTech (London, UK). FITC-or PE-conjugated mouse mAb to CD40, CD80, MHC-II, CD4, CD25, and isotype control mAbs were purchased from BD PharMingen (San Diego, CA). FITC-dextran was purchased from SigmaAldrich. Microbead-conjugated mAbs to CD11c and CD4 were purchased from Miltenyi Biotec (Bergisch Gladbach, Germany). The replication-defective recombinant Ad-VNG was constructed by our laboratory, the frame of VNG vector is pcDNA3.1/myc-His(-)B (Invitrogen), in which myc-His(-)B was substituted with green fluorescent protein (GFP). The titers were determined by PFU assay. Enzyme-linked immunosorbent assay (ELISA) kits for IL-10 and IL-12p40 were purchased from Endogen.
Preparation and genetic modification of BMDCs
Generation of BMDCs was performed as described previously (22) . Briefly, bone marrow cells were flushed from the femurs and tibiae of C57BL/6 mice. These cells were cultured with RPMI 1640 medium containing 10% FBS in the presence of recombinant murine GM-CSF (10 ng/ml) and IL-4 (1 ng/ml) for 6 days to obtain iDCs, and then purified > 95% CD11c + by positive immunomagnetic selection with anti-CD11c-conjugated microbeads. Purified iDCs were plated in a 12-well plate and transfected with Ad-SOCS1 or Ad-VNG at a multiplicity of infection of 1:100 for 24 h in serum-free RPMI 1640, then washed twice, and cultured in RPMI 1640 supplemented with recombinant mouse GM-CSF. The resulting iDCs were designated as DC-SOCS1 or DC-VNG. The mDCs were generated by stimulating iDCs with LPS (1 g/ml) for 2 days. The iDCs, DC-SOCS1, and DC-VNG were stimulated by LPS for 48 h, then harvested for SOCS1 expression detection by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot or phenotype detection (Iab, CD40, CD80) by FACS. Supernatants were collected for IL-10 and IL-12p40 measurement by ELISA.
RT-PCR analysis of SOCS1 expression
Total RNA was isolated from DCs, DC-VNG, or DC-SOCS1 with TRIzol (Gibco BRL, Carlsbad, CA) according to the manufacturer's directions. The cDNA was synthesized from 1 g total RNA by extension with oligo(dT)18 primer and SuperScript II (200 U; Gibco BRL). Primers used for PCR amplification were 5'-AGT GTG ACG TTG ACA TCC GT-3' and 5'-GCA GCT CAG TAA CAG TCC GC-3' (-actin), and 5'-TCC GAT TAC CGG CGC ATC ACG-3' and 5'-CTC CAG CAG CTC GAA AAG GCA-3' (SOCS1). PCR amplification from cDNA was performed in a final volume of 50 l containing 2.5 mM magnesium dichloride, 1.25 U Ex Taq polymerase (TaKaRa, Dalian, China), and 1 M specific primers. Cycling conditions were 94°C for 30 s, 57°C (SOCS1) or 50°C (-actin) for 30 s, and 72°C for 60 s (GeneAmp 9600 PCR System, Perkin-Elmer, Wellesley, MA). The optimum number of cycles was 30 for SOCS1 and -actin. All PCR products were resolved by 1.5% agarose gel electrophoresis and visualized by staining with ethidium bromide.
Western blot analysis
To detect SOCS1 expression in iDCs, DC-VNG, or DC-SOCS1, blots were probed overnight with 1:500 diluted anti-SOCS1 Ab and then incubated with 1:5,000 diluted horseradish peroxidase (HRP)-conjugated anti-mouse immunoglobulin G (IgG) for 1 h at room temperature. Proteins were visualized following the manufacturer's directions (Pierce, Rockford, IL). The quantification of SOCS1 to -actin levels was performed by densitometry analysis.
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Flow cytometric analysis BMDC surface phenotypes were detected by flow cytometry. Briefly, cells were washed and stained with FITC-or PEconjugated anti-mouse CD40, CD80, MHC-II, CD4, and CD25 Abs that were diluted to the optimal concentrations. Cells were then washed twice and analyzed by FACS. All flow cytometric analyses were performed using appropriate isotype controls.
Phagocytosis assay
Mannose receptor-mediated endocytosis was measured as the cellular uptake of FITC-dextran with FACS. DCs (1 × 10 6 cells) were resuspended in 250 l of media containing 25 g/ml FITC-dextran (4000 MW, Sigma-Aldrich). After 2 h of incubation with the FITC-dextran at 4°C or 37°C, cells were washed three times with ice-cold PBS with 1% FBS, then stained for cell surface CD11c, and analyzed by FACS. CD11c-positive cells were gated, and the fraction of FITC-positive cells was calculated.
Enzyme-linked immunosorbent assay (ELISA)
The IL-12p40 and IL-10 levels were assayed using ELISA kits according to the manufacturer's instructions. To test T-cell hyporesponsiveness, BALB/c splenic CD4 + T cells were incubated at a fixed stimulator:responder cell ratio with C57BL/6 derived iDCs, DC-VNG or DC-SOCS1 (primary MLR). After three days, residual cells were incubated with FITC-anti-H-2K b (PharMingen), followed by MACS anti-FITC microbeads to remove C57BL/6 cells. The BALB/c T cells were rested in culture medium for a further two days and then re-stimulated with irradiated (30 Gy) splenocytes from C57BL/6, or C3H mice, for 72 h (secondary MLR). Proliferation assays were pulsed with 1 Ci [ 3 H] thymidine for the final 18 h of the 72-hour period and incorporated radioactivity was measured in a liquid scintillation counter.
Mixed lymphocyte reaction (MLR) and assay for allogeneic T-cell hyporesponsiveness
Heart transplantation
Cervical heterotopic heart transplantation was performed in accordance with routine procedures in our laboratory (23) . BALB/c mice were subjected to allogeneic cardiac transplantation using C57BL/6 donors. The contraction of heart grafts was monitored daily by two independent observers without prior knowledge of the treatment protocol. Rejection was defined as total cessation of cardiac contraction. To assess the effect of donor-derived DCs on allograft survival, animals received 2 × 10 6 cells i.v. 7 days before heart transplantation.
Statistical analysis
Statistical comparisons between experimental and control groups were performed using the Mann-Whitney U test. Data were presented as mean ± SD. Graft survival between groups of transplanted animals was compared using the log-rank test for comparison of survival curves. A value of p < 0.05 was considered statistically significant.
Results
Transduction of BMDCs with Adv-SOCS1 increases SOCS1 expression
Our previous work demonstrated that adenoviral-mediated gene transduction to BMDCs is efficient (24) . Purified iDCs were transduced with Ad-SOCS1 or Ad-VNG at an MOI of 100 for 24 h. Transduction efficiency was analyzed by fluorescent microscope using VNG as the readout. Based on the results of VNG transduction, > 85% of DCs were successfully transduced at day 7 (data not shown). To determine the expression of SOCS1 in transduced DCs (DC-SOCS1), SOCS1 mRNA and protein expressions were determined by RT-PCR and Western blot analysis. SOCS1 transduction resulted in significantly increased SOCS1 mRNA transcription and protein expression, compared with negative controls including Ad-VNG and nontreated controls (Figure 1 ).
To identify whether this increased expression can exist persistently, DC-SOCS1 was cultured in medium for 1 week and then analyzed with Western blot. No significant reduction of SOCS1 expression was observed between fresh DC-SOCS1 and DC-SOCS1 cultured for 1 week (data not shown). These results indicated that Ad-SOCS1 can effectively transfer the SOCS1 gene into DCs to express persistently.
DC-SOCS1 resistant to maturation expresses a high level of IL-10 and exhibits regulatory DC properties
To examine the effect of SOCS1 gene expression on DC maturation, the phenotype of DC-SOCS1 was analyzed by FACS. Like iDCs, DC-SOCS1 expressed lower levels of CD40, CD80, and Ia (Figure 2A expressed higher levels of CD40, CD80, and Ia than both iDCs and DC-SOCS1, indicating that the adenoviral vector itself influenced the DC phenotype. However, SOCS1 could effectively inhibit maturation induced by the vector itself. LPS is a well-characterized inducer of DC maturation (25) . To investigate whether SOCS1 gene expression could maintain iDC in an immature state in the presence of exogenous maturation stimuli, DC-SOCS1, DC-VNG, or iDCs were stimulated with LPS (1 g/ml) for 24 h. Following LPS stimulation, iDCs and DC-VNG expressed high levels of MHC class II, CD40, and CD80, whereas DC-SOCS1 retained low levels of these maturation markers (Figure 2A) . Furthermore, while LPS-stimulated iDCs and DC-VNG secreted high levels of IL-12 ( Figure 2B ), DC-SOCS1 expressed low level of this maturation-associated cytokine but a higher level of IL-10 ( Figure 2C ). Together, these results suggested that SOCS1 gene expression inhibited LPSmediated maturation of iDCs but facilitated a high level of IL-10 secretion.
Antigen phagocytosis is a prerequisite for antigenpresentation. In contrast with immature DC, mature DC exhibits a weak phagocytosis function. To examine DC phagocytic ability, purified iDCs, DC-VNG, or DC-SOCS1 were incubated with FITC-conjugated dextran and analyzed by FACS. Both iDCs and DC-SOCS1 displayed high phagocytic ability ( Figure 2D) ; however, the phagocytic ability of iDCs or DC-VNG decreased after LPS stimulation. In contrast, DC-SOCS1 exhibited high phagocytic ability, like iDCs after LPS stimulation. These results implied that DC-SOCS1 restricted LPS-induced maturation. Taken together, the results suggested that the gene transfer of SOCS1 arrested maturation and activation of DCs, even in the presence of maturation and activation stimuli.
DC-SOCS1 reduces allostimulatory activities and induces allogeneic T-cell hyporesponsiveness
The allostimulatory activities of mDCs, iDCs, DC-SOCS1, and DC-VNG were investigated with allogeneic MLR. CD4 LPS stimulation at different ratios. DC-SOCS1 induced weak proliferation of allogeneic T cells ( Figure 3A) . Moreover, LPS-stimulated DC-SOCS1 also induced significantly weaker proliferation of allogeneic T cells than LPSstimulated iDCs (p < 0.01), suggesting that SOCS1 could effectively inhibit the allostimulatory activity of DCs ( Figure  3B ).
The ability of DC-SOCS1 to induce T-cell hyporesponsiveness to alloantigen re-stimulation was investigated. The CD4 + T cells primed with iDCs or DC-VNG in primary MLR could expand significantly in response to stimulation with C3H splenocytes (H-2 k , third-party) ( Figure 3C ). Their response to re-stimulation with C57BL/6 splenocytes in secondary MLR was weaker than that of those primed by allogeneic mature DCs (C57BL/6), which displayed a vigorous response to C57BL/6 splenocytes in secondary MLR. In contrast, the responses of T cells exposed to DC-SOCS1 in primary MLR to secondary MLR challenge with C57BL/6 splenocytes were significantly weaker than those of iDCs or DC-VNG primed T cells; however, the T cells did retain the capacity to proliferate in response to third-party C3H splenocytes (H-2 k , third-party) ( Figure 3D ). Moreover, this DC-SOCS1-induced alloantigen-specific T-cell hyporesponsiveness could not be reversed by the addition of exogenous IL-2 (data not shown). These results indicated that DC-SOCS1 had a greater capacity to induce donor-specific
T-cell hyporesponsiveness in vitro.
To analyze the cytokine profiles of CD4 + T cells after stimulation with DCs, iDCs, DC-VNG, DC-SOCS1 or LPStreated DCs were cocultured with allogeneic CD4 + T cells. Levels of IFN- and IL-2 were detected in the supernatants of allo-MLR by ELISA. Control DCs induced a predominant Th1 cytokine profile, with high levels of IFN-, and a low level of IL-10 ( Figure 3E ). In contrast, T cells cocultured with DC-SOCS1 produced high-level of IL-10, and lowerlevel of IFN- ( Figure 3F ). CD4 + T cells were cultured with allogeneic iDCs, DC-VNG or DC-SOCS1 in MLR for 5 days, then T cells expanded in the presence of 50 U/ml IL-2 for further 10 days; then intracellular cytokine expression of T cells were detected. T cells exposed repeatedly to DC-SOCS1 were confirmed to express high level of IL-10 and low level of IFN- by intracellular cytokine staining ( Figure 3G ). These results suggested that DC-SOCS1 effectively induced the generation of IL-10-producing T cells.
DC-SOCS1 infusion prolongs cardiac allograft survival
To determine the effect of DC-SOCS1 on allograft survival in vivo, BALB/c recipients were infused with 2 × 10 6 C57BL/6-derived iDCs, DC-VNG, or DC-SOCS1 by tail vein 7 days before cervical heterotopic heart transplantation. Compared with the untreated control group, the survival of allograft in recipients pretreated with iDCs or DC-VNG was modestly prolonged, with median graft survival time (MST) increased from 7 days to 11 or 9.5 days. In contrast, DC-SOCS1 exerted a marked tolerogenic effect and prolonged MST to 24.5 days ( Figure 4A ). These results indicated that DC-SOCS1 pretreatment can significantly prolong allograft survival.
DC-SOCS1 infusion induces Treg generation in vivo CD4
+ CD25 + Treg plays a crucial role in the modulation of various immune responses, including autoimmune responses and immunity to transplants, allergens, tumors, and infectious microbes (26) . Therefore, we investigated whether DC-SOCS1 infusion prolonged allograft survival by inducing the generation of Treg, which could maintain tolerance in vivo. Recipients that received iDCs, DC-SOCS1, or DC-VNG infusion were sacrificed on day 15 post transplantation. Spleen and cervical lymph node cells were purified by positive immunomagnetic selection with anti-CD4-conjugated microbeads. Purified T cells were sorted by FACS to analyze the proportion of CD4 + CD25 + T cells. Compared with those in untreated recipients, the percentage of CD4 + CD25 + T cells moderately increased in iDCs-and DC-VNG-infused recipients, but significantly increased in DC-SOCS1-infused recipients ( Figure 4B ). Furthermore, a higher percentage of Foxp3 + CD4 + T cells were detected in DC-SOCS1-infused mice than in control mice ( Figure 4C ).
Discussion
SOCS1 protein was discovered as an important negative regulator of cytokine signaling by suppressing the Janus kinase/signal transducers and activators of transcription (JAK-STAT) pathway (27) . Recent studies revealed the pivotal role of SOCS1 in regulating the phenotype and function of immune cells by negatively regulating the response of immune cells to cytokines (28) . Kimura demonstrated that LPS could activate JAK2 and STAT5, which were involved in IL-6 induction, but SOCS1 could selectively inhibit this process (29) . Flagellin could activate T cells via the T cell receptor (TCR) pathway; however, prestimulation with flagellin could induce SOCS1 expression, which would arrest TCR-mediated activation by nuclear factor of activated T-cell (NFAT) inhibition (30) . Moreover, IFN- can induce the expression of CD40, one of the important costimulatory molecules for antigen presentation, in primary macrophages via the recruitment of STAT-1 and RNA Pol II and histone modifications on the CD40 promoter. However, SOCS1 inhibited CD40 expression by blocking this process (31) . Emerging evidence indicates that SOCS1 protein is involved in regulating the maturation and function of immune cells. This result inspired us to test what happens in DCs with the overexpression of SOCS1 protein. Our data suggested that SOCS1 overexpression could keep DCs in a steady immature status with low levels of costimulatory and MHC molecules and stronger phagocytosis activity even when facing stimuli. Interestingly, we noticed that DC-SOCS1 could secrete high levels of IL-10 upon stimulation with LPS, unlike iDCs or DC-VNG. Reports indicate that overexpression of the SOCS-3 gene promotes IL-10 production, and that IL-10 can induce SOCS1 and SOCS-3 expressions. We also observed that overexpression of SOCS1 can promote IL-10 expression of DCs (32, 33) . These findings attracted speculation that IL-10 very likely plays a pivotal role in the differentiation process of regulatory DCs. The previous study demonstrated that the granulocyte colony stimulating factor (G-CSF) could promote the generation of regulatory DC in vitro; however, neutralization of IL-10 significantly inhibited this process, suggesting that IL-10 involved in regulatory DC generation (34) . BMDC could translate into regulatory DC when genetically engineered to express IL-10, and induce longlasting antigen-specific tolerance with an experimental asthma model (35) . Thus, the phenotype and cytokine secretion properties of DC-SOCS1 are similar to those of regulatory DCs.
As we and others previously reported, regulatory DCs could be induced from iDCs by means of specific modification with certain immunosuppressive molecules. For example, VIP administration during the early phases of DC differentiation promoted the generation of murine regulatory DCs with the capacity to induce CD4 + Treg cells, prevent the progression of autoimmune disorders, and reduce the deleterious consequences of acute graft-versus-host disease (GVHD) after allogeneic transplantation (6, 7) . In addition, it was reported that regulatory DCs not only produced anergic T cells and IL-10-producing T cells, but also possibly could expand the number of CD4 + CD25 + Foxp3 + Treg cells (36) . Therefore, we further tested the allostimulatory activities and allogeneic responsiveness of DC-SOCS1 with MLR. Our data suggested that DC-SOCS1 could induce the weak proliferation of allogeneic T cells and promote the generation of IL-10-producing T cells, confirming the immune regulatory function of DC-SOCS1 in vitro.
Next, we investigated whether DC-SOCS1 could induce allogeneic hyporesponsiveness in vivo in mice with cervical heterotopic heart transplantation. The challenge for iDC in vivo included the natural maturation process and endogenous stimuli. To test whether resistance to the maturation of DC-SOCS1 in vivo, we infused DC-SOCS1 into recipients 7 days before transplantation. As our data revealed, DC-SOCS1 infusion could prolong allograft survival; however, iDC and DC-VNG infusion could not achieve a comparable effect, perhaps due to the reason mentioned earlier. In organ transplantation recipients, Tregs help maintain immune homeostasis by suppressing the proliferative and cytokine responses of naïve T cells, as well as macrophages, DC, NK, NK-T, and B cells (31) . To evaluate whether the tolerogenic properties of DC-SOCS1 are mediated through Tregs, we determined the proportion of CD4 + CD25 + T cells in CD4 + T cells isolated from transplantation recipients. Our data confirmed that DC-SOCS1 infusion could induce an increase in CD4 + CD25 + Treg generation. Several mechanisms might account for the Treg induction. Naïve T cell activation simultaneously needs two kinds of signals provided by mDCs: one mediated by MHC/antigen TCR interaction, and the other mediated by costimulatory molecule interaction (e.g., CD80/CD86-CD28 and CD40-CD40L). Recent studies revealed a more important role of the CD40 signal pathway in the switch of tolerogenesis and stimulogenesis for T cells (37) . The characteristic phenotype of DC-SOCS1 expressing low levels of costimulatory molecules, especially CD40, could not provide enough activation signals. This result was consistent with tolerogenic characteristics. In addition, IL-10 secreted from DC-SOCS1 could also contribute to Treg generation. It has been demonstrated that IL-10 could suppress costimulatory molecule expression of DCs and keep DCs in a steady immature status. However, IL-10 itself could also induce regulatory T cell generation.
Here, it must be mentioned that the adenoviral vector itself could trigger an innate immune response when used in vitro or in vivo (38) . According to cell type, the adenoviral vector promoted the surface expression of maturation marker molecules in antigen-presenting cells through a Toll-like receptor 9 (TLR-9) dependent or independent manner (39) . However, the adenoviral expression of SOCS1 could reduce the immune response of the adenovirus vector itself, due to interference with the JAK-STAT pathway (40) . Our experiment results also indicated that DCs induced an increase in CD40, CD80, and Ia expression upon being transfected with Ad-VNG; however, this promotion of maturation effect initiated by the vector itself could be efficiently inhibited when turning to Ad-SOCS1.
In summary, our study demonstrated that SOCS1-overexpressed DCs exhibited regulatory DC properties. This finding may have important implications for the development of therapeutic strategies based on SOCS1 gene modification for the prevention of allograft rejection.
